Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€64.41

€64.41

3.090%
1.93
3.090%
€115.81
 
19.09.24 / Tradegate WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for DexCom

sharewise wants to provide you with the best news and tools for DexCom, so we directly link to the best financial data sources.

News

Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U: https://mms.businesswire.com/media/20240918060382/en/2246397/5/ROSTER_DEXU-2024_16x9_v4_STILL.jpg
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company’s

2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200: https://g.foolcdn.com/editorial/images/790278/patient-and-doctor-talking.jpg
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200

With $200, one can afford many lottery tickets, one of which could be a winner. However, the odds of winning meaningful money by playing the lottery are minuscule. Investing in the stock market

3 Reasons DexCom Looks Like a No-Brainer Buy Right Now: https://g.foolcdn.com/editorial/images/789980/doctor-talking-to-a-patient-while-making-notes.jpg
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now

DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels.

But the stock has been performing poorly this year amid

Is DexCom a Millionaire-Maker Stock?: https://g.foolcdn.com/editorial/images/788047/dexcom-g6-full-family.png
Is DexCom a Millionaire-Maker Stock?

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps put

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available: https://mms.businesswire.com/media/20240826019839/en/2223727/5/Image_3.jpg
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the

2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200: https://g.foolcdn.com/editorial/images/786943/dexcom-g6-full-family.png
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200

The stock market remains one of the best ways to grow capital over time. And although having millions in the bank might help, a more accessible -- and perfectly sensible -- strategy is to invest

2 Growth Stocks to Buy at a Discount: https://g.foolcdn.com/editorial/images/787136/happy-pregnant-mother.jpg
2 Growth Stocks to Buy at a Discount

If you're looking for stocks on sale in the current market, despite the broader gains that major indices have clocked, many companies have responded in different ways. While a stock trading at a

1 Growth Stock Down 43% to Buy Right Now: https://g.foolcdn.com/editorial/images/786837/continuous-glucose-monitor.jpg
1 Growth Stock Down 43% to Buy Right Now

Attractive investment opportunities can sometimes arise when investors react emotionally to short-term events. Some of these events revolve around the earnings season, when a company releases

RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents: https://mms.businesswire.com/media/20240814728352/en/2215556/5/dexcom-g7-studio-photography-man-holding-sensor_1.jpg
RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest innovation, the Dexcom G7 Continuous

Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?: https://g.foolcdn.com/editorial/images/785826/businessman-checking-his-phone.jpg
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?

When a stock falls over a cliff after earnings, it can put investors into an unnerving situation: Should you average down, or simply get out of the stock entirely? It's not always an easy question

These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?: https://g.foolcdn.com/editorial/images/785566/dexcom-g6-full-family.png
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?

Earnings season can be a volatile time in the stock market. Some corporations produce financial results that are impressive enough to send their share prices soaring, while others move in the exact

Down 40% in 1 Day, Is DexCom Stock Still a Buy?: https://g.foolcdn.com/editorial/images/785365/two-investors-look-at-figures.jpg
Down 40% in 1 Day, Is DexCom Stock Still a Buy?

July 25 was a difficult day for DexCom (NASDAQ: DXCM) shareholders, with the company's second-quarter earnings release crashing the stock by 40%. To make matters worse, at the moment it's unclear

DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?: https://g.foolcdn.com/editorial/images/785036/diabetes-cgm-man-in-wheelchair.jpg
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?

Going into 2024, DexCom's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from

2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000: https://g.foolcdn.com/editorial/images/784337/listening-laptop-podcast-smiling-happy.jpg
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000

Bull markets come and go, and give way to bear markets, and come back again. The stock market has a remarkable habit of steadily rising with the passage of time. For investors who stay invested

2 Magnificent Growth Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/784339/man-reading-paper-report-statement-and-using-laptop.jpg
2 Magnificent Growth Stocks to Buy Right Now

Not all stocks have responded to the bull market in the some way. While many businesses have followed the broader trend of steadily rising, some stocks are trading down considerably and even coming

Why DexCom Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/784772/dexcom-cgm-devices-and-apps.png
Why DexCom Stock Is Crashing Today

Shares of DexCom (NASDAQ: DXCM) were crashing 39.9% lower as of 10:20 a.m. ET on Friday. The huge sell-off came after the continuous glucose monitoring (CGM) systems maker announced its

DexCom (DXCM) Q2 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
DexCom (DXCM) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

DexCom (NASDAQ: DXCM)Q2 2024 Earnings CallJul 25, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Dexcom G7 Now Connects Directly to Apple Watch in the U.S.: https://mms.businesswire.com/media/20240605396939/en/2150620/5/Dexcom_G7_DTW_Product.jpg
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now

Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems: https://mms.businesswire.com/media/20240603553579/en/2149024/5/dexcom-g7-sensor-iphone-7.2-mmol_%282%29_%281%29.jpg
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or

Bull Market Buys: 2 Growth Stocks to Own for the Long Haul: https://g.foolcdn.com/editorial/images/778453/physicians-in-an-operating-room.jpg
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul

Every good thing must come to an end -- and, eventually, the bull market we're experiencing will, too. Long-term investors must prepare for that to happen at some point.

One of the best ways to do

Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?: https://g.foolcdn.com/editorial/images/778863/diabetes-type-1.jpg
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?

Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes

DexCom (DXCM) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
DexCom (DXCM) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

DexCom (NASDAQ: DXCM)Q1 2024 Earnings CallApr 25, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

2 Growth Stocks to Buy Hand Over Fist in April: https://g.foolcdn.com/editorial/images/771856/physician-shaking-patients-hand.jpg
2 Growth Stocks to Buy Hand Over Fist in April

Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.

Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being

Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium


DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at